The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[4-(N-Methyl-N-[(3-carbamoylfuroxan-4-yl)methyl]-1-hydroxybutylidene]bis(phosphonic) acid ID: ALA1088773
PubChem CID: 46885776
Max Phase: Preclinical
Molecular Formula: C9H18N4O10P2
Molecular Weight: 404.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(CCCC(O)(P(=O)(O)O)P(=O)(O)O)Cc1no[n+]([O-])c1C(N)=O
Standard InChI: InChI=1S/C9H18N4O10P2/c1-12(5-6-7(8(10)14)13(16)23-11-6)4-2-3-9(15,24(17,18)19)25(20,21)22/h15H,2-5H2,1H3,(H2,10,14)(H2,17,18,19)(H2,20,21,22)
Standard InChI Key: LNBBYSVYUHGJNA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 25 0 0 0 0 0 0 0 0999 V2000
10.5031 -12.1190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1860 -12.5820 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8386 -12.0770 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5578 -11.2984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7341 -11.3283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2273 -10.6773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0197 -10.6148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8427 -10.6730 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3046 -9.9894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2037 -11.4148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0267 -11.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3877 -12.2148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2107 -12.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5717 -13.0149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6726 -11.5895 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
16.0333 -12.2708 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
16.4417 -12.9833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7458 -11.8542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8292 -12.4833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0833 -11.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6667 -10.7625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3833 -11.1708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9125 -12.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5377 -9.9129 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4102 -10.7906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
12 13 1 0
13 14 1 0
4 7 1 0
13 15 1 0
2 3 1 0
13 16 1 0
7 8 1 0
16 17 2 0
3 4 2 0
16 18 1 0
8 9 1 0
16 19 1 0
4 5 1 0
15 20 2 0
8 10 1 0
15 21 1 0
5 1 2 0
15 22 1 0
10 11 1 0
1 23 1 0
1 2 1 0
6 24 2 0
11 12 1 0
6 25 1 0
M CHG 2 1 1 23 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.21Molecular Weight (Monoisotopic): 404.0498AlogP: -2.38#Rotatable Bonds: 9Polar Surface Area: 234.59Molecular Species: ACIDHBA: 8HBD: 6#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 0.69CX Basic pKa: 5.77CX LogP: -7.39CX LogD: -10.27Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.19Np Likeness Score: -0.45
References 1. Lolli ML, Rolando B, Tosco P, Chaurasia S, Di Stilo A, Lazzarato L, Gorassini E, Ferracini R, Oliaro-Bosso S, Fruttero R, Gasco A.. (2010) Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs)., 18 (7): [PMID:20299227 ] [10.1016/j.bmc.2010.02.058 ]